Phenotypes and personalized medicine in the acute respiratory distress syndrome. 2020

Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
Department of Anesthesia, University of California San Francisco, San Francisco, CA, USA. Michael.matthay@ucsf.edu.

Although the acute respiratory distress syndrome (ARDS) is well defined by the development of acute hypoxemia, bilateral infiltrates and non-cardiogenic pulmonary edema, ARDS is heterogeneous in terms of clinical risk factors, physiology of lung injury, microbiology, and biology, potentially explaining why pharmacologic therapies have been mostly unsuccessful in treating ARDS. Identifying phenotypes of ARDS and integrating this information into patient selection for clinical trials may increase the chance for efficacy with new treatments. In this review, we focus on classifying ARDS by the associated clinical disorders, physiological data, and radiographic imaging. We consider biologic phenotypes, including plasma protein biomarkers, gene expression, and common causative microbiologic pathogens. We will also discuss the issue of focusing clinical trials on the patient's phase of lung injury, including prevention, administration of therapy during early acute lung injury, and treatment of established ARDS. A more in depth understanding of the interplay of these variables in ARDS should provide more success in designing and conducting clinical trials and achieving the goal of personalized medicine.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D057285 Precision Medicine Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile. Individualized Medicine,Predictive Medicine,P Health,P-Health,Personalized Medicine,Theranostics,Medicine, Individualized,Medicine, Personalized,Medicine, Precision,Medicine, Predictive,Theranostic

Related Publications

Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
November 2022, Respiratory research,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
February 2017, American journal of respiratory and critical care medicine,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
February 2019, Current opinion in critical care,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
February 2019, Seminars in respiratory and critical care medicine,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
July 2021, Critical care (London, England),
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
October 2022, Lancet (London, England),
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
January 2021, American journal of respiratory and critical care medicine,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
June 2014, Annals of the American Thoracic Society,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
July 2022, Critical care clinics,
Michael A Matthay, and Yaseen M Arabi, and Emily R Siegel, and Lorraine B Ware, and Lieuwe D J Bos, and Pratik Sinha, and Jeremy R Beitler, and Katherine D Wick, and Martha A Q Curley, and Jean-Michel Constantin, and Joseph E Levitt, and Carolyn S Calfee
March 2003, Der Anaesthesist,
Copied contents to your clipboard!